Muscular Dystrophy (MD) Mouse Model Development Service

Muscular dystrophy (MD) encompasses a group of heterogeneous genetic disorders characterized by progressive muscle weakness and degeneration. The identification of dystrophin in duchenne muscular dystrophy (DMD) marked a pivotal moment, leading to a deeper understanding of MD's molecular basis. Animal models, particularly genetically engineered mice, have since become indispensable tools. They provide invaluable platforms for elucidating disease pathogenesis and rigorously testing novel therapeutic strategies, accelerating the journey from basic research to clinical application.

How Our Muscular Dystrophy (MD) Mouse Models Can Assist Your Project

Creative Biolabs' MD mouse models service offers specific deliverables and problem-solving capabilities designed to advance your preclinical research. We provide the essential platforms for understanding disease mechanisms, validating drug targets, and rigorously testing the efficacy and safety of novel therapeutic compounds. Our comprehensive approach ensures that you receive actionable insights to propel your drug development forward.

Discover How We Can Help - Request a Consultation

Workflow

Our workflow is meticulously designed to provide a seamless and efficient research experience, tailored to your specific project needs.

Required Starting Materials:

To initiate a project, clients typically provide:

Specific Gene Targets/Mutations: Details regarding the genetic basis of the MD you are targeting.
Compound Structures/Therapeutic Hypotheses: Information on the therapeutic agents to be tested or the scientific rationale behind your approach.
Project Scope and Endpoints: Clear objectives, desired outcome measures, and any specific timelines.

Fig.1 Workflow of our Muscular Dystrophy (MD) Mouse Models Development Services Can Assist Your Project. (Creative Biolabs Original)

Final Deliverables:

Upon project completion, you will receive:

Detailed Study Reports: Comprehensive documents outlining all experimental procedures, raw data, processed data, statistical analyses, and scientific conclusions.
High-Resolution Histopathological Images: Annotated images supporting the morphological and molecular findings.
Raw Data Sets: Complete raw data files from all functional and molecular assays, ensuring transparency and enabling further independent analysis.

Estimated Timeframe:

The typical timeframe for MD mouse model studies at CBL ranges from 12 to 24 weeks, depending on the complexity of the model, the number of experimental groups, study endpoints, and the frequency of compound administration. Custom studies or those requiring extensive phenotyping may extend beyond this range.

Why Choose Us?

Choosing CBL for your MD mouse model studies means partnering with a team that combines deep scientific expertise with a commitment to delivering high-quality, translational data. Our unique features and advantages ensure that your research is conducted with the utmost precision and efficiency.

We leverage a diverse and well-characterized portfolio of MD mouse models, including the widely recognized mdx model for DMD, and models for sarcoglycanopathies, laminin α2 chain deficiencies, and dysferlinopathies. Our extensive experience spans various therapeutic modalities, including gene therapy, cell therapy, and pharmacological interventions.

Experience the Advantage - Get a Quote Today

Customer Reviews:

"Exceptional Efficacy Data! Using CBL's MD mouse models in our research has significantly improved our ability to generate robust efficacy data for our gene therapy candidates. The detailed histopathological analyses provided crucial insights into muscle regeneration and fibrosis, far exceeding our previous in-house capabilities." (6 Months Ago), Dr. A**a Smith

"Streamlined Preclinical Validation. CBL's MD mouse models facilitated the rapid preclinical validation of our novel small molecule. Their expertise in study design and precise functional assessments allowed us to confidently compare our compound's performance against existing standards, demonstrating clear advantages in muscle strength and reducing our development timeline." (1 Year Ago), Prof. J**n Doe

"Unparalleled Model Characterization. The comprehensive characterization of the mdx/utrn double mutant model provided by CBL was instrumental in understanding the severe cardiomyopathy associated with our therapeutic target. Their detailed reports and expert consultations helped us refine our therapeutic strategy, ensuring a more targeted and effective approach." (3 Months Ago), Dr. M**y Lee

Muscular Dystrophy (MD) Mouse Models

CBL offers a comprehensive suite of well-characterized MD mouse models, each meticulously developed to mimic specific human MD conditions. These models are critical for preclinical research, enabling detailed studies of disease progression, therapeutic efficacy, and safety.

Models	Description
Dystrophinopathy Models	mdx Mouse: The most widely used naturally occurring model for DMD. It exhibits muscle degeneration and regeneration cycles, closely mimicking aspects of the human disease. Ideal for initial efficacy screening and understanding basic dystrophic pathology. mdx/utrn Double Mutant Mouse: Lacking both dystrophin and utrophin, this model presents a more severe and rapidly progressive dystrophic phenotype, including significant cardiomyopathy. It is considered a more clinically relevant model for studying severe DMD and cardiac involvement.
Sarcoglycanopathy Models	Genetically engineered mice with specific disruptions in α-, β-, γ-, or δ-sarcoglycans. These models faithfully recapitulate the progressive muscular dystrophy seen in human Limb-Girdle Muscular Dystrophies (LGMDs 2C-2F). Many of these models also develop a cardiac phenotype, making them valuable for evaluating therapies targeting both skeletal and cardiac muscle.
Laminin α2 Chain Deficiency Models	Including dy, dy2J, dy3K, and dyw strains. These models exhibit muscle pathology and, in some cases, dysmyelination of the peripheral nervous system, reflecting the severe congenital muscular dystrophies caused by laminin α2 chain mutations. They are crucial for studying early-onset MD and the impact on multiple tissues.
Dysferlinopathy Models	The SJL mouse strain, which carries a deletion in the dysferlin gene, serves as a natural model for Limb-Girdle Muscular Dystrophy type 2B (LGMD 2B) and Miyoshi myopathy. This model is essential for investigating therapies for these specific forms of MD characterized by muscle inflammation and progressive weakness.

What We Can Offer

At CBL, we are dedicated to empowering your MD research with a suite of unparalleled capabilities and services, meticulously designed to meet the unique demands of your project.

Comprehensive Model Portfolio: Access to a diverse and extensively characterized range of MD mouse models, including gold-standard dystrophinopathy models (mdx, mdx/utrn), sarcoglycanopathy models, laminin α2 chain deficiency models, and dysferlinopathy models, ensuring the perfect match for your research.
Tailored Study Design & Execution: Benefit from fully customized experimental protocols, meticulously designed by our neurology experts to optimize your study for specific MD types, therapeutic modalities (gene, cell, pharmacological), and desired endpoints, maximizing the relevance and impact of your data.
Advanced Phenotyping & Functional Assessment: Leverage our state-of-the-art capabilities for precise in vivo functional assessments, including muscle strength, motor function, and behavioral analyses, providing quantitative evidence of therapeutic efficacy.
Deep Mechanistic Insights: Gain comprehensive understanding through our advanced histopathological and molecular analyses, revealing the cellular and biochemical changes induced by your therapy, from muscle regeneration to protein expression.
Expert Consultation & Support: Partner with our seasoned scientific team, offering over 20 years of experience in neuromuscular research, to guide you through model selection, study design, data interpretation, and strategic planning for your MD therapeutic development.

Related Services

To further support your research and development goals related to MD, CBL offers a range of complementary services and specialized options:

Ready to discuss your next MD research project or learn more about how our MD mouse models can benefit your therapeutic development?

Contact Our Team for More Information and to Discuss Your Project.

For Research Use Only. Not For Clinical Use.

In Vivo Services

Hot Products

Antibodies

Cells

Kits

Tracers

Gene Therapy Tools

Biospecimens

Cell Assay Reagents